Who we are
Advent is a world-class contract manufacturing organization and part of the IRBM group. We are located outside Rome, within the IRBM campus. Our facility complies with the regulatory guidelines of both FDA and EMA and has been granted the authorization to produce investigational medicinal products by the Italian National Regulatory Authority (AIFA).
Advent is currently focused on the development and manufacture of investigational lots of adenovirus-based vaccines.
We have an unprecedented track record in clinical lot release with all batches manufactured since our inception being successfully released.
What we do
We have worked for many years with human and non-human adenoviruses and the team has a wealth of experience in the manufacture of vaccines, generation of master cell banks and master virus banks.
The team can offer a series of services as an integrated package or as a stand-alone service, depending on your needs. For example:
- Construction, rescue and production of research-grade recombinant viral vectors
- Preclinical process development and scale-up
- Analytical development and validation
- GMP manufacturing for gene products
- GMP Quality Control
- QP release
- Quality Assurance and Regulatory Affairs support
Why work with us
ADVENT’s mission is to maximize quality and cost effectiveness of clinical lot production on behalf of our customers. This is achieved by the outstanding scientific support the team can provide in such areas as analytical method development, process development/validation, in-process assay release setup and qualification and cell banking.
Our clients are our highest priority. We strive to provide you with the best possible services, to ensure your clinical trials run smoothly and successfully.
As a part of the IRBM group, we are steeped in science. Every day, our passion drives us to continue to learn, develop, and stay at the forefront of science and innovation.